Ocuphire Pharma Investor Day Presentation Deck slide image

Ocuphire Pharma Investor Day Presentation Deck

DR DME 17 APX3330 Human PK and Safety Summary Presented by: Peter Kaiser, MD Cleveland Clinic Cole Eye Institute Peter Kaiser, MD Harvard Medical School Ocuphire ā— Chaney Family Endowed Chair in Ophthalmology Research, Professor of Ophthalmology, Cleveland Clinic Lerner College of Medicine and Cole Eye Institute Clinical research expert, serving as a Study Chairman of 5 major, multi-center, international trials, and principal investigator for numerous studies for AMD, DR, and other retinal disorders. Major contributions to medical literature having authored 7 textbooks, more than 250 peer-reviewed papers Recognized by American Academy of Ophthalmology and American Society of Retina Specialist with Senior Achievement Awards.
View entire presentation